The Team at Seroba Kernel

Graham Fagg

Graham Fagg is a Partner at Seroba Kernel Life Sciences (Dublin) and a Partner at Rosetta Capital (London). Graham has been working with Seroba since 2003 and currently sits on the Boards of portfolio companies, Provesica, Quanta Fluid Solutions and Xention.

Graham has extensive experience in pharmaceutical R&D and the life science investment sectors across Europe and North America.  He held management roles at Ciba (now Novartis, Basel) in drug discovery, business development, corporate venturing, research planning and strategic partnership management; and at Catalyst BioMedica, a subsidiary of the Wellcome Trust (London), where he was founding Managing Director.  His investment experience encompasses international strategic investment and corporate venturing activities at Ciba, including a period at Accel Partners (San Francisco); pre-seed and early-stage investment activities at Catalyst BioMedica; and corporate finance and ongoing international secondary fund management at Rosetta.  

Graham received a PhD in neurobiology from University College London in 1976.